期刊
ANALYTICAL CHEMISTRY
卷 85, 期 17, 页码 8298-8303出版社
AMER CHEMICAL SOC
DOI: 10.1021/ac4015885
关键词
-
资金
- National Institute of Environmental Health Sciences Superfund Basic Research [P42 ES04699]
- National Institute of Occupational Safety and Health Western Center for Agricultural Health and Safety [U50 OH07550]
- CounterACT Program
- National Institutes of Health Office of the Director
- National Institute of Neurological Disorders and Stroke [U54NS079202]
- National Natural Science Foundation of China [31171702]
- Special Fund for Agro-scientific Research in the Public Interest [201203094]
- Earmarked Fund for China Agriculture Research System [CARS-13]
- China Scholarship Council
Anti-idiotypic antibodies recognize the antigenic determinants of an antibody, thus they can be used as surrogate antigens. Single-domain antibodies from camlid heavy-chain antibodies with the benefit features of small size, thermostability, and ease in expression, are leading candidates to produce anti-idiotypic antibodies. In this work, we constructed an antibody phage library from the mRNA of an alpaca immunized with an antiaflatoxin monoclonal antibody (mAb) 1C11. Three anti-idiotypic VHH antibodies were isolated and applied to immunoassay toward aflatoxin as a coating antigen. The best immunoassay developed with one of these VHH antibodies shows an IC50 of 0.16 ng/mL toward aflatoxin B, and cross-reactivity toward aflatoxin B-2, G(1), and G(2) of 90.4%, 54.4%, and 37.7%, respectively. The VHH-based immunoassay was successfully applied to the analysis of peanuts, corn, and rice, which are the predominant commodities regularly contaminated by aflatoxins. A good correlation (r(2) = 0.89) was found between the data obtained from the conventional ELISA and the ELISA based on a VHH coating antigen for, the analysis of aflatoxins in peanuts and feedstuff. The use of biotechnology in developing the surrogate, the absence of standard aflatoxin and organic solvents in the synthesis procedures, and the reproducibility of the VHH antibody makes it an ideal strategy for replacing conventional synthesized antigens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据